Mayne Pharma Group (AU:MYX) has released an update.
Mayne Pharma Group has released its 2024 Corporate Governance Statement, emphasizing its commitment to high ethical standards and adherence to the ASX Corporate Governance Principles. The Board of Directors underscores the importance of maintaining transparency and integrity while guiding the company’s strategic direction. Investors may find assurance in the company’s dedication to strong governance practices and risk management.
For further insights into AU:MYX stock, check out TipRanks’ Stock Analysis page.
